Published in Dement Geriatr Cogn Disord on January 01, 2002
Living alone and depressive symptoms: the influence of gender, physical disability, and social support among Hispanic and non-Hispanic older adults. J Gerontol B Psychol Sci Soc Sci (2009) 1.04
Living alone with dementia: lack of awareness adds to functional and cognitive vulnerabilities. Int Psychogeriatr (2010) 0.95
Potentially Unsafe Activities and Living Conditions of Older Adults with Dementia. J Am Geriatr Soc (2016) 0.78
Under-provision of medical care for vascular diseases for people with dementia in primary care: a cross-sectional review. Br J Gen Pract (2013) 0.77
Participant-Informant Relationships Affect Quality of Life Ratings in Incipient and Clinical Alzheimer Disease. Am J Geriatr Psychiatry (2016) 0.75
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology (2005) 21.67
Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial. BMJ (1999) 5.36
A reevaluation of the duration of survival after the onset of dementia. N Engl J Med (2001) 4.86
Physical activity and risk of cognitive impairment and dementia in elderly persons. Arch Neurol (2001) 4.56
Apolipoprotein E polymorphism and Alzheimer's disease. Lancet (1993) 4.47
Accumulation of deficits as a proxy measure of aging. ScientificWorldJournal (2001) 4.47
Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology (1990) 4.41
Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet (1997) 4.39
The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp1 gene. J Exp Med (1995) 3.86
A phenomenology of scut. Ann Intern Med (1991) 3.46
A brief clinical instrument to classify frailty in elderly people. Lancet (1999) 3.27
The recognition, assessment and management of dementing disorders: conclusions from the Canadian Consensus Conference on Dementia. CMAJ (1999) 3.14
Pharmacotherapy of Alzheimer's disease: is there a need to redefine treatment success? Int J Geriatr Psychiatry (2001) 3.09
Safety and efficacy of galantamine in subjects with mild cognitive impairment. Neurology (2008) 2.79
A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease. Neurology (2001) 2.78
Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm Suppl (2000) 2.56
Development of a functional measure for persons with Alzheimer's disease: the disability assessment for dementia. Am J Occup Ther (1999) 2.53
The effects of donepezil in Alzheimer's disease - results from a multinational trial. Dement Geriatr Cogn Disord (1999) 2.30
HLA B*44: protective effects in MS susceptibility and MRI outcome measures. Neurology (2010) 2.29
HSV-1 in brain and risk of Alzheimer's disease. Lancet (1998) 2.21
Management of Parkinson's disease a review of current and new therapies. Can J Neurol Sci (1999) 2.16
Relation between severity of Alzheimer's disease and costs of caring. CMAJ (1998) 2.12
Prevalence and types of dementia in the very old: results from the Canadian Study of Health and Aging. Neurology (1994) 2.10
The Bcg/Ity/Lsh locus: genetic transfer of resistance to infections in C57BL/6J mice transgenic for the Nramp1 Gly169 allele. Infect Immun (1996) 2.02
Conceptualisation and measurement of frailty in elderly people. Drugs Aging (2000) 2.00
Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease. Proc Natl Acad Sci U S A (1995) 1.91
Proposed diagnostic criteria for apathy in Alzheimer's disease and other neuropsychiatric disorders. Eur Psychiatry (2009) 1.86
The risk of dementia and death after delirium. Age Ageing (1999) 1.84
Natural resistance to intracellular infections: Nramp1 encodes a membrane phosphoglycoprotein absent in macrophages from susceptible (Nramp1 D169) mouse strains. J Immunol (1996) 1.78
Health of family members caring for elderly persons with dementia. A longitudinal study. Ann Intern Med (1994) 1.67
Competencies required for the practice of geriatric medicine as a consultant physician. CMAJ (1989) 1.67
Cognitive impairment in the nondemented elderly. Results from the Canadian Study of Health and Aging. Arch Neurol (1995) 1.66
Mild cognitive impairment: a concept in evolution. J Intern Med (2014) 1.65
Economic evaluation of donepezil in moderate to severe Alzheimer disease. Neurology (2004) 1.65
Screening for PS1 mutations in a referral-based series of AD cases: 21 novel mutations. Neurology (2001) 1.64
Calcium-channel blockers and cognitive function in elderly people: results from the Canadian Study of Health and Aging. CMAJ (1999) 1.60
Androgen receptor antagonists (antiandrogens): structure-activity relationships. Curr Med Chem (2000) 1.59
The psychological and physical health of family members caring for an elderly person with dementia. J Clin Epidemiol (1992) 1.58
Bovine spongiform encephalopathy and Creutzfeldt-Jakob disease: implications for physicians. CMAJ (1996) 1.57
The iron transport protein NRAMP2 is an integral membrane glycoprotein that colocalizes with transferrin in recycling endosomes. J Exp Med (1999) 1.53
Hypothalamic-pituitary-adrenal activity in aged, cognitively impaired and cognitively unimpaired rats. J Neurosci (1990) 1.51
Prevalence and outcomes of vascular cognitive impairment. Vascular Cognitive Impairment Investigators of the Canadian Study of Health and Aging. Neurology (2000) 1.49
Effect of a geriatric consultation service on management of patients in an acute care hospital. CMAJ (1987) 1.48
The prevalence of cognitive impairment in an elderly Canadian population. Acta Psychiatr Scand (1989) 1.48
Illness presentation in elderly patients. Arch Intern Med (1995) 1.43
Behavioral problems in nursing home residents. Safe ways to manage dementia. Postgrad Med (1995) 1.38
Vascular dementia : incidence and risk factors in the Canadian study of health and aging. Stroke (2000) 1.35
Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats. Neuroscience (1993) 1.34
Canadian Consensus Conference on Dementia: a physician's guide to using the recommendations. CMAJ (1999) 1.34
Multidimensionality in instrumental and basic activities of daily living. J Clin Epidemiol (1998) 1.32
Feasibility and measurement properties of the functional reach and the timed up and go tests in the Canadian study of health and aging. J Gerontol A Biol Sci Med Sci (2000) 1.32
Progression of impairment in patients with vascular cognitive impairment without dementia. Neurology (2001) 1.31
Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases. J Neurochem (1992) 1.28
The recognition, assessment and management of dementing disorders: conclusions from the Canadian Consensus Conference on Dementia. Can J Neurol Sci (2001) 1.27
Folate deficiency and decreased brain 5-hydroxytryptamine synthesis in man and rat. Nature (1979) 1.26
Mapping of genetic modulators of natural resistance to infection with Salmonella typhimurium in wild-derived mice. Genomics (1998) 1.24
Effect of smoking on the accumulation of deficits, frailty and survival in older adults: a secondary analysis from the Canadian Study of Health and Aging. J Nutr Health Aging (2009) 1.22
Testing the measurement properties of the Short Form-36 Health Survey in a frail elderly population. J Clin Epidemiol (1998) 1.21
Cell-specific and inducible Nramp1 gene expression in mouse macrophages in vitro and in vivo. J Leukoc Biol (1997) 1.20
Interrater reliability of the Clinical Dementia Rating in a multicenter trial. J Am Geriatr Soc (2000) 1.19
Clinical effects of choline in Alzheimer's disease. Lancet (1978) 1.18
Frailty in relation to the risk of falls, fractures, and mortality in older Chinese adults: results from the Beijing Longitudinal Study of Aging. J Nutr Health Aging (2012) 1.17
The use of goal attainment scaling in a geriatric care setting. J Am Geriatr Soc (1992) 1.17
Tryptophan, 5-hydroxyindoleacetic acid and indoleacetic acid in human cerebrospinal fluid: interrelationships and the influence of age, sex, epilepsy and anticonvulsant drugs. J Neurol Neurosurg Psychiatry (1980) 1.16
Lentivirus vectors using human and simian immunodeficiency virus elements. J Virol (1999) 1.15
Standardization of the diagnosis of dementia in the Canadian Study of Health and Aging. Neuroepidemiology (1996) 1.15
Rasch analysis of the hierarchical assessment of balance and mobility (HABAM). J Clin Epidemiol (2000) 1.14
The atypical presentation of infection in old age. Age Ageing (1987) 1.13
The Canadian Study of Health and Aging: risk factors for vascular dementia. Stroke (1997) 1.13
The Nramp2/DMT1 iron transporter is induced in the duodenum of microcytic anemia mk mice but is not properly targeted to the intestinal brush border. Blood (2000) 1.12
Chronic obstructive pulmonary disease: effects of hypoxia on neurological and neuropsychological measures. J Clin Exp Neuropsychol (1997) 1.11
Do long tests yield a more accurate diagnosis of dementia than short tests? A comparison of 5 neuropsychological tests. Arch Neurol (1996) 1.11
Assessing the clinical importance of statistically significant improvement in anti-dementia drug trials. Neuroepidemiology (2001) 1.10
The disability assessment for dementia scale: a 12-month study of functional ability in mild to moderate severity Alzheimer disease. Alzheimer Dis Assoc Disord (2001) 1.10
Transitions in cognitive status in relation to frailty in older adults: a comparison of three frailty measures. J Nutr Health Aging (2011) 1.09
The Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity of a revised assessment of neuropsychiatric symptoms in dementia. Int Psychogeriatr (2010) 1.08
Factors predictive of the need for levodopa therapy in early, untreated Parkinson's disease. The Parkinson Study Group. Arch Neurol (1995) 1.06
Predictive value of apolipoprotein E genotyping in Alzheimer's disease: results of an autopsy series and an analysis of several combined studies. Ann Neurol (1994) 1.06
Active site residues in m-calpain: identification by site-directed mutagenesis. FEBS Lett (1995) 1.06
A Hierarchical Assessment of Balance and Mobility. Age Ageing (1995) 1.05
Goal attainment scaling as a measure of clinically important change in nursing-home patients. Age Ageing (1999) 1.05
First International Pharmacoeconomic Conference on Alzheimer's Disease: report and summary. Alzheimer Dis Assoc Disord (1998) 1.05
Development of a scleroderma-like illness during therapy with L-5-hydroxytryptophan and carbidopa. N Engl J Med (1980) 1.05
Cross-national interrater agreement on the clinical diagnostic criteria for dementia. WHO-PRA Age-Associated Dementia Working Group, WHO-Program for Research on Aging, Health of Elderly Program. Neurology (1994) 1.04
Sleep in Alzheimer's disease: further considerations on the role of brainstem and forebrain cholinergic populations in sleep-wake mechanisms. Sleep (1995) 1.04
Alzheimer's Disease International and International Working Group for Harmonization of Dementia Drug Guidelines for research involving human subjects with dementia. Alzheimer Dis Assoc Disord (1999) 1.04